Vitura Health Ltd
Vitura Health Limited is engaged in a diversified digital health business.
The business
Vitura Health Limited is engaged in a diversified digital health business. The Company, through its subsidiaries, operates businesses, including Burleigh Heads Cannabis, Canview, Doctors on Demand, Cortexa, CDA Clinics, and Cannadoc. Its sales and distribution segment covers the sale and distribution of medical products, including medicinal cannabis, psychedelic drugs and smoking cessation products, and potentially others. Its clinics and services segment covers the provision of medical consultations and related services. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy, and supplier online ecosystem, Canview, which sells and distributes 430+ therapeutic product and device SKUs within Australia from about 60 international and domestic brands. Doctors on Demand is a telehealth platform business that provides primary health solutions. It also operates the Candor Medical brand, which provides prescription treatments, including access to medicinal cannabis.
Small Caps Research
No research on Vitura Health Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise VIT based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million
VIT hits profitability: Doctors on Demand tops 1 million consultations since FY2024; revenue rises 54% to FY2026 Q1-Q3, EBITDA positive at 5%.

Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products
Vitura Health strikes MedReleaf distribution deal, targeting up to $15m extra annual revenue via Canview across 4,700 pharmacies.

Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.